AKT1 and hepatocellular carcinoma: Additionally, VEGF inhibitors can heighten the apoptosis sensitivity of hepatocellular carcinoma cells to etoposide in vitro through the suppression of protein kinase B (PKB/AKT) and extracellular signal-regulated kinase (ERK) pathways activation [21].